These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1329 related items for PubMed ID: 24464774
1. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study. Takada T, Sakata Y, Miyata S, Takahashi J, Nochioka K, Miura M, Tadaki S, Shimokawa H, CHART-2 Investigators. Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774 [Abstract] [Full Text] [Related]
3. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction. Maeder MT, Kaye DM. Int J Cardiol; 2012 Mar 08; 155(2):249-56. PubMed ID: 21035207 [Abstract] [Full Text] [Related]
4. Comparison of 5-Year Outcomes After Coronary Artery Bypass Grafting in Heart Failure Patients With Versus Without Preserved Left Ventricular Ejection Fraction (from the CREDO-Kyoto CABG Registry Cohort-2). Marui A, Nishiwaki N, Komiya T, Hanyu M, Tanaka S, Kimura T, Sakata R, CREDO-Kyoto CABG Registry Cohort-2 Investigators. Am J Cardiol; 2015 Aug 15; 116(4):580-6. PubMed ID: 26092271 [Abstract] [Full Text] [Related]
5. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Cheng RK, Cox M, Neely ML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC. Am Heart J; 2014 Nov 15; 168(5):721-30. PubMed ID: 25440801 [Abstract] [Full Text] [Related]
6. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Bavishi C, Ather S, Bambhroliya A, Jneid H, Virani SS, Bozkurt B, Deswal A. Am J Cardiol; 2014 Jun 01; 113(11):1834-8. PubMed ID: 24837261 [Abstract] [Full Text] [Related]
8. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction. Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, Watanabe M, Yao A, Hirata Y, Kazuma K, Nagai R. J Cardiol; 2012 Jul 01; 60(1):23-30. PubMed ID: 22445598 [Abstract] [Full Text] [Related]
11. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction. Slee A, Saad M, Saksena S. J Interv Card Electrophysiol; 2019 Sep 01; 55(3):325-331. PubMed ID: 30887281 [Abstract] [Full Text] [Related]
13. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction. Lund LH, Benson L, Dahlström U, Edner M, Friberg L. JAMA; 2014 Nov 19; 312(19):2008-18. PubMed ID: 25399276 [Abstract] [Full Text] [Related]
14. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Brouwers FP, de Boer RA, van der Harst P, Voors AA, Gansevoort RT, Bakker SJ, Hillege HL, van Veldhuisen DJ, van Gilst WH. Eur Heart J; 2013 May 19; 34(19):1424-31. PubMed ID: 23470495 [Abstract] [Full Text] [Related]
18. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort. Quiroz R, Doros G, Shaw P, Liang CS, Gauthier DF, Sam F. Am J Cardiol; 2014 Feb 15; 113(4):691-6. PubMed ID: 24484862 [Abstract] [Full Text] [Related]